Camilo Jimenez 5th International Symposium on Phaeochromocytoma and Paraganglioma 2017

Abstracts this author is presenting:

• A Phase 2 Study to Evaluate the Effects of Cabozantinib in Patients with unresectable Metastatic Pheochromocytomas and Paragangliomas — Symposium 9: Management II
• Clinical Trials for Patients with Malignant Pheochromocytomas and Paragangliomas: What Have We Learned? Where Are We Going? — Symposium 7: Management I - New Horizons